ZMYM6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.420600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.480030E-01
Normal-vs-Stage2
3.490400E-01
Normal-vs-Stage3
2.036000E-01
Normal-vs-Stage4
3.933400E-01
Stage1-vs-Stage2
9.200200E-01
Stage1-vs-Stage3
1.226970E-01
Stage1-vs-Stage4
5.782600E-01
Stage2-vs-Stage3
8.548200E-02
Stage2-vs-Stage4
5.075600E-01
Stage3-vs-Stage4
1.220230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.377200E-01
Normal-vs-AfricanAmerican
1.892220E-01
Normal-vs-Asian
6.657900E-02
Caucasian-vs-AfricanAmerican
8.817600E-01
Caucasian-vs-Asian
6.858400E-01
AfricanAmerican-vs-Asian
7.311600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.216800E-01
Normal-vs-Female
3.697600E-01
Male-vs-Female
1.903050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.897000E-01
Normal-vs-Age(41-60Yrs)
4.367800E-01
Normal-vs-Age(61-80Yrs)
3.161200E-01
Normal-vs-Age(81-100Yrs)
2.480600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.670600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.070800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.326800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.678300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.378900E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.972410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.598600E-01
Normal-vs-Daily Drinker
2.983800E-01
Normal-vs-Weekly Drinker
3.508000E-02
Normal-vs-Occasional Drinker
4.548400E-01
Normal-vs-Social Drinker
1.181380E-01
Non Drinker-vs-Daily Drinker
4.611800E-01
Non Drinker-vs-Weekly Drinker
5.698600E-01
Non Drinker-vs-Occasional Drinker
6.580000E-03
Non Drinker-vs-Social Drinker
3.448100E-02
Daily Drinker-vs-Weekly Drinker
9.432800E-01
Daily Drinker-vs-Occasional Drinker
6.417700E-02
Daily Drinker-vs-Social Drinker
1.808380E-01
Weekly Drinker-vs-Occasional Drinker
8.590300E-02
Weekly Drinker-vs-Social Drinker
2.087800E-01
Occasional Drinker-vs-Social Drinker
7.109200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.426030E-01
Normal-vs-Grade 2
1.200250E-02
Normal-vs-Grade 3
5.110000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.027200E-01
Grade 1-vs-Grade 3
2.459200E-01
Grade 1-vs-Grade 4
1.426030E-01
Grade 2-vs-Grade 3
9.622800E-01
Grade 2-vs-Grade 4
1.200250E-02
Grade 3-vs-Grade 4
5.110000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.851600E-01
Normal-vs-NonDiabetic
3.285800E-01
Diabetic-vs-NonDiabetic
2.341000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.270800E-01
Normal-vs-NoPancreatitis
3.196400E-01
Pancreatitis-vs-NoPancreatitis
9.877800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.495600E-02
Normal-vs-N1
3.493000E-01
N0-vs-N1
6.626400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.546600E-01
Normal-vs-TP53-NonMutant
3.580200E-01
TP53-Mutant-vs-TP53-NonMutant
9.535400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
